Journey Medical Corp
NASDAQ:DERM
Cash Flow Statement
Cash Flow Statement
Journey Medical Corp
| Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||
| Net Income |
(20)
|
(44)
|
(45)
|
(41)
|
(41)
|
(30)
|
(38)
|
(39)
|
(12)
|
(4)
|
(4)
|
1
|
(18)
|
(15)
|
(8)
|
(9)
|
(9)
|
|
| Depreciation & Amortization |
3
|
2
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
3
|
3
|
3
|
4
|
4
|
4
|
|
| Change in Deffered Taxes |
(7)
|
2
|
0
|
5
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
2
|
3
|
4
|
5
|
4
|
4
|
4
|
4
|
3
|
3
|
4
|
5
|
6
|
6
|
6
|
6
|
|
| Other Non-Cash Items |
16
|
23
|
24
|
20
|
10
|
6
|
6
|
9
|
8
|
7
|
8
|
5
|
5
|
6
|
6
|
5
|
6
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
3
|
|
| Change in Working Capital |
13
|
15
|
15
|
15
|
6
|
6
|
13
|
17
|
18
|
(2)
|
(6)
|
(17)
|
(18)
|
(4)
|
(8)
|
(3)
|
(5)
|
|
| Cash from Operating Activities |
5
N/A
|
(2)
N/A
|
(1)
+40%
|
1
N/A
|
(13)
N/A
|
(14)
-5%
|
(15)
-14%
|
(8)
+47%
|
18
N/A
|
5
-71%
|
1
-77%
|
(8)
N/A
|
(28)
-250%
|
(9)
+67%
|
(7)
+24%
|
(3)
+61%
|
(4)
-45%
|
|
| Investing Cash Flow | ||||||||||||||||||
| Capital Expenditures |
(10)
|
(10)
|
(30)
|
(30)
|
(21)
|
(20)
|
(5)
|
(5)
|
(5)
|
(5)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(10)
N/A
|
(10)
N/A
|
(30)
-200%
|
(30)
N/A
|
(21)
+29%
|
(20)
+6%
|
(5)
+75%
|
(5)
N/A
|
(5)
N/A
|
(5)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(15)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||
| Net Issuance of Common Stock |
19
|
52
|
52
|
37
|
33
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Net Issuance of Debt |
4
|
5
|
17
|
20
|
17
|
17
|
5
|
(8)
|
(23)
|
(9)
|
(9)
|
9
|
19
|
9
|
8
|
3
|
4
|
|
| Other |
(2)
|
(4)
|
(4)
|
(3)
|
(2)
|
(1)
|
0
|
(0)
|
(0)
|
4
|
6
|
6
|
6
|
8
|
10
|
10
|
17
|
|
| Cash from Financing Activities |
21
N/A
|
53
+156%
|
64
+21%
|
54
-15%
|
47
-13%
|
16
-65%
|
5
-69%
|
(8)
N/A
|
(23)
-186%
|
(5)
+79%
|
(3)
+33%
|
15
N/A
|
26
+72%
|
17
-34%
|
19
+12%
|
14
-26%
|
21
+52%
|
|
| Change in Cash | ||||||||||||||||||
| Net Change in Cash |
16
N/A
|
41
+159%
|
33
-19%
|
26
-22%
|
13
-49%
|
(17)
N/A
|
(15)
+11%
|
(21)
-39%
|
(10)
+52%
|
(5)
+55%
|
(2)
+55%
|
7
N/A
|
(2)
N/A
|
(7)
-211%
|
(3)
+58%
|
(4)
-21%
|
2
N/A
|
|
| Free Cash Flow | ||||||||||||||||||
| Free Cash Flow |
(5)
N/A
|
(12)
-144%
|
(31)
-157%
|
(29)
+9%
|
(34)
-20%
|
(34)
+2%
|
(20)
+39%
|
(13)
+36%
|
13
N/A
|
0
-98%
|
1
+392%
|
(8)
N/A
|
(28)
-250%
|
(24)
+13%
|
(7)
+71%
|
(3)
+61%
|
(4)
-45%
|
|